Contract Services Methods Development
Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology
In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...
November 01, 2024 | Interview
Centivax Partners with Australia’s BioCina for cGMP Manufacturing of Universal Influenza Vaccine
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with Centivax...
October 10, 2024 | News
Synexa Life Sciences Acquires Alderley Analytical Ltd, Strengthening Bioanalytical Capabilities and Expanding European Reach
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, based near ...
October 08, 2024 | News
SK Bioscience Acquires IDT Biologika to Accelerate Global Growth and Dominate the CDMO Industry
- SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in r...
October 02, 2024 | News
Bloomage Completes Cutting-Edge Pilot-Scale Testing Platform to Accelerate Biomanufacturing Innovation
Bloomage, a global leader specializing in hyaluronic acid and other bioactive substance innovations, has announced the completion of its new pilot-scale te...
September 26, 2024 | News
Nanoform and Takeda Collaborate on Pre-Clinical Development of Innovative Plasma-Derived Therapies
Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, announced that it is to enter into a pre-clinical development agreemen...
August 16, 2024 | News
Andelyn Biosciences Partners with Broad Institute to Enhance Gene Therapy Platform with MyoAAV Plasmids
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has entere...
August 07, 2024 | News
Full-Life Technologies and SK Biopharmaceuticals Ink $571.5 Million Deal for Exclusive Rights to Radiopharmaceutical FL-091
Full-Life Technologies ("Full-Life"), a fully integrated global radiotherapeutics company, announced that it has entered into a license agreement wit...
July 17, 2024 | News
AGC Biologics Completes Production of VAR2 Pharmaceuticals' Cancer-Targeting Antibodies
AGC Biologics announced the completion of work with VAR2 Pharmaceuticals on the production of the company’s two antibody candidates targeti...
April 25, 2024 | News
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj
Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved for Commercial use in South Korea as an adjuvant cell th...
February 27, 2024 | News
Charles River and Wheeler Bio Forge Strategic Alliance to Streamline Drug Development Process
This partnership aims to enhance therapeutic discovery and expedite the journey to Investigational New Drug (IND) submission by combining Charles R...
February 23, 2024 | News
WuXi XDC and Celltrion Collaborate on Comprehensive Antibody-Drug Conjugate (ADC) Services
Under the collaboration, Celltrion will delegate WuXi XDC as primary service provider on each of the integrated projects, from process development to GMP m...
January 24, 2024 | News
Bora Pharmaceuticals Expands Globally with $210 Million Acquisition of Upsher-Smith
BioPharma APAC Perspective: Bora's acquisition of Upsher-Smith for $210 million marks a pivotal moment for the pharmaceutical giant. This strategic move n...
January 18, 2024 | News
WuXi Biologics and BioNTech Partner on Monoclonal Antibody Research Agreement
Under the terms of the agreement, WuXi Biologics leverages its proprietary antibody discovery technology platforms (R in CRDMO) to discover two undisclosed...
January 11, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
